We have built our business around the concept of putting known, trusted and effective molecules into innovative delivery mechanisms so that patients can benefit from improved effectiveness through reduced or improved dosing methods. This approach has led to an impressive list of pioneering ‘firsts', including the world's first prolonged release morphine tablets, the first 7-day analgesic patch and the UK's first prolonged release analgesic combining an opioid agonist with an antagonist.

Our largest area of expertise lies in analgesics, but we also have a rapidly expanding oncology portfolio and a very promising respiratory franchise. We have a healthy product pipeline with a number of analgesic, oncology and respiratory products at various stages of clinical development and scheduled for submission to the regulatory authorities in the near future.

Our culture is underpinned by our core values and leadership attributes, which are the behavioural parameters within which we all work. Our employees have played, and continue to play, a significant role in developing and shaping our values and leadership attributes. In addition to the values and leadership attributes you might expect for a successful pharmaceutical company, we have a very human side to our expected behaviours because our business has been built around the importance of people and the relationships that we form with them. Our values and leadership attributes are:

• Innovation and intellectual capability
• Passion and drive
• Honesty
• Respect
• Excellent people skills

For the past 4 years, our employees have completed the Best Companies survey and we have entered both the Best Companies accreditation scheme and the Sunday Times Top 100 Best Companies to Work For in the UK. We are proud to have achieved the maximum 3-star status each year, as well as appearing in the Sunday Times Top 100. Our position in 2010 was number 5.